Disc Medicine Inc. (NASDAQ:IRON) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Leerink Partners raised its price target of the stock to $115 from $110 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results